Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Annette Regan, Assistant Professor of Epidemiology, University of San Francisco

RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

Only one antiviral medication is approved by the FDA for RSV treatment, and it is administered through a nebulizer. BonNontawat/iStock via Getty Images Plus

For many parents, respiratory syncytial virus – or RSV – which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is a common respiratory virus that circulates every fall and winter and is a common cause of lung infections in young children.

RSV can be difficult to distinguish from other respiratory infections since the symptoms are common to other illnesses – runny nose, sneezing, congestion, coughing, fever, decreased appetite and wheezing. In most cases, RSV is mild and will improve at home. However, in certain cases, it can cause severe illness and require hospital treatment.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.